Rethinking survival analysis: advancing beyond the hazard ratio? Universiteit Hasselt
Randomized clinical trials are the foundation of evidence-based medicine , offering vital insights into the efficacy of interventions. Although these trials guide clinical decision-making through hypothesis testing, relying solely on a significant P-value is insufficient; it is essential to convey in addition the magnitude of the treatment effect. In cardiovascular trials, the primary endpoint frequently comprises (a composite of) time-to-event ...